ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 251 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,751 | +6.3% | 132 | +22.2% | 0.00% | – |
Q2 2023 | $2,587 | +49.5% | 108 | +17.4% | 0.00% | – |
Q1 2023 | $1,731 | +18.2% | 92 | 0.0% | 0.00% | – |
Q4 2022 | $1,465 | -75.6% | 92 | -76.8% | 0.00% | -100.0% |
Q3 2022 | $6,000 | +200.0% | 396 | +204.6% | 0.00% | – |
Q2 2022 | $2,000 | -50.0% | 130 | -22.2% | 0.00% | -100.0% |
Q1 2022 | $4,000 | +100.0% | 167 | +68.7% | 0.00% | – |
Q4 2021 | $2,000 | 0.0% | 99 | 0.0% | 0.00% | -100.0% |
Q3 2021 | $2,000 | 0.0% | 99 | +52.3% | 0.00% | – |
Q1 2021 | $2,000 | +100.0% | 65 | +441.7% | 0.00% | – |
Q4 2020 | $1,000 | – | 12 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |